Skip to main content
MMSI logo

MMSI · Merit Medical Systems Inc · Documents

Track MMSI — free
Market Cap
$5.19B
Shares
59.92M
Volume · Nov 16 64.12K Avg daily vol (3M) 669.51K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Oct 30
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $339.85M ▲ 7.8% Net income $28.44M ▲ 10.1% Diluted EPS $0.48 ▲ 9.1%
Aug 1
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $338M ▲ 5.6% Net income $35.73M ▲ 76.5% Diluted EPS $0.61 ▲ 74.3%
Apr 30
Quarterly report 10-Q FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $323.51M ▲ 8.7% Net income $28.24M ▲ 36.4% Diluted EPS $0.48 ▲ 33.3%
Feb 28
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $1.26B ▲ 9.2% Net income $94.41M ▲ 26.7% Diluted EPS $1.62 ▲ 25.6%
2023
Oct 26
Quarterly report 10-Q FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $315.23M ▲ 9.8% Net income $25.83M ▲ 69.2% Diluted EPS $0.44 ▲ 63.0%
Jul 28
Quarterly report 10-Q FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $320.06M ▲ 8.5% Net income $20.25M ▲ 32.3% Diluted EPS $0.35 ▲ 29.6%
Apr 28
Quarterly report 10-Q FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $297.57M ▲ 8.0% Net income $20.7M ▲ 96.3% Diluted EPS $0.36 ▲ 100.0%
Feb 24
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $1.15B ▲ 7.1% Net income $74.52M ▲ 53.8% Diluted EPS $1.29 ▲ 53.6%
2022
Oct 28
Quarterly report 10-Q FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $287.18M ▲ 7.5% Net income $15.27M ▲ 27.6% Diluted EPS $0.27 ▲ 28.6%
Aug 5
Quarterly report 10-Q FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $294.98M ▲ 5.2% Net income $15.3M ▲ 211.2% Diluted EPS $0.27 ▲ 200.0%
Showing 51–100 of 151 documents
Key facts CIK 856982 CUSIP 589889104 13F (30d) 339 filings 302 filers Visit website Investor relations